134 results on '"Verhamme, A"'
Search Results
2. Methods to assess COPD medications adherence in healthcare databases: a systematic review
3. Epidemiology of unexplained chronic cough in adults: a population-based study
4. The interrelationship of chronic cough and depression: a prospective population-based study
5. Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO)
6. Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study
7. Incidence and predictors of asthma exacerbations in middle-aged and older adults: the Rotterdam Study
8. Effect of β-blockers on the risk of COPD exacerbations according to indication of use: the Rotterdam Study
9. Trends in outpatient azithromycin prescribing in respiratory diseases
10. Methods to assess adherence to COPD medication in electronic healthcare databases: a systematic review
11. Sarcopenia in older people with chronic airway diseases: the Rotterdam study
12. Epigenome-wide association study on diffusing capacity of the lung
13. Prevalence and incidence of, and risk factors for chronic cough in the adult population: the Rotterdam Study
14. Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
15. COPD is associated with an increased risk of peripheral artery disease and mortality
16. Methods to assess COPD medications adherence in healthcare databases: a systematic review.
17. Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA+LAMA in asthma patients - TAILOR study
18. Characteristics of medication errors among respiratory drugs within the Food and Drug Administration’s Adverse Event Reporting System
19. Determinants of type of step-up treatment following medium-dose ICS/LABA in asthma patients - TAILOR study
20. Determinants of type of step-up treatment following medium-dose ICS/LABA in asthma patients - TAILOR study
21. Predictors of treatment response to high-dose ICS/LABA or medium-dose ICS/LABA+LAMA in asthma patients - TAILOR study
22. Characteristics of medication errors among respiratory drugs within the Food and Drug Administration’s Adverse Event Reporting System
23. Inhibiting RIPK1 kinase activity is protective in experimental models of COPD
24. Stability of blood eosinophils over time in patients with asthma
25. Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
26. Persistent chronic cough and vitamin D deficiency
27. Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial
28. Persistent chronic cough and vitamin D deficiency
29. Stability of blood eosinophils over time in patients with asthma
30. Late Breaking Abstract - Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof of concept clinical trial
31. Real-world treatment patterns of newly diagnosed patients with asthma and/or COPD
32. Sarcopenia in older people with chronic airway diseases: the Rotterdam study
33. Chronic Cough is associated with higher levels of Systemic Immune Inflammation Index
34. Real world use of opioids in COPD patients
35. Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): a modified Delphi exercise to identify a core dataset for asthma and COPD studies
36. (in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study)
37. The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study
38. Pharmacogenetics of inhaled corticosteroid response in adults with asthma
39. Longitudinal changes in appendicular skeletal muscle mass among asthma and COPD subjects: The Rotterdam Study
40. Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity
41. Association between reperfusion therapy and outcomes in patients with acute pulmonary embolism and right heart thrombi
42. Towards Optimum Reporting of Pulmonary Effectiveness Databases and Outcomes (TORPEDO): a modified Delphi exercise to identify a core dataset for asthma and COPD studies
43. Chronic Cough is associated with higher levels of Systemic Immune Inflammation Index
44. Hokusai post-PE study: a follow-up study on long-term outcomes of pulmonary embolism in patients treated with edoxaban vs warfarin
45. (in)Appropriate LAMA Prescribing in Asthma patients: a Cohort Analysis (the ALPACA study)
46. Longitudinal changes in appendicular skeletal muscle mass among asthma and COPD subjects: The Rotterdam Study
47. The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study
48. Pharmacogenetics of inhaled corticosteroid response in adults with asthma
49. Bronchial airway inducible expression and methylation QTL mapping identifies a single nucleotide polymorphism predicting inhaled corticosteroids response heterogeneity
50. Real world use of opioids in COPD patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.